SLC25A39 binds and modulates PRDX1 to suppress ROS-induced necroptosis in hepatocellular carcinoma

This publication has 34 references indexed in Scilit:

• ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion
  Drug Resistance Updates, 2025
• Discovery of Natural Resorcylic Acid Lactones as Novel Potent Copper Ionophores Covalently Targeting PRDX1 to Induce Cuproptosis for Triple-Negative Breast Cancer Therapy
  ACS Central Science, 2025
• HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1
  Redox Biology, 2024
• Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis
  Molecular Cell, 2023
• Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
  Cell, 2022
• The SLC25 Mitochondrial Carrier Family: Structure and Mechanism
  Trends in Biochemical Sciences, 2019
• Hepatocellular carcinoma
  The Lancet, 2018
• Joint Linkage and Association Analysis with Exome Sequence Data Implicates SLC25A40 in Hypertriglyceridemia
  The American Journal of Human Genetics, 2013
• The mitochondrial ADP/ATP carrier (SLC25 family): Pathological implications of its dysfunction
  Molecular Aspects of Medicine, 2013
• The mitochondrial transporter family SLC25: Identification, properties and physiopathology
  Molecular Aspects of Medicine, 2013